Access cutting-edge obesity treatment through this phase 3 clinical trial at a research site in Tucson. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Tucson location
Preparing your pre-screening questions…
Access obesity specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related obesity treatment provided free
Check if you qualify for this obesity clinical trial in Tucson, AZ
No-Cost Study Care
Local to Tucson
Convenient for AZ residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
Study GSBR-1290-12 is a Phase 3 pivotal, multicenter, global, randomized, placebo-controlled, double-blind study to investigate the long-term efficacy, safety, and tolerability of 3 maintenance doses of aleniglipron once daily (QD) compared with placebo, when used in combination with a reduced-calorie diet and increased physical activity. All participants will be randomized to at least 76 weeks of treatment to evaluate the effects on long term body weight changes, tolerability, and safety. In addition, the study will compare the effects between aleniglipron and placebo on blood pressure (BP), lipid parameters, patient-reported outcomes.
Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
Yes, this clinical trial (NCT07654361) has an active research site in Tucson, AZ that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for obesity treatment options in Tucson, AZ, this clinical trial (NCT07654361) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Tucson research site is actively enrolling participants for this phase 3 clinical trial. You'll receive care from experienced obesity specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all obesity clinical trials near you to find additional studies recruiting in your area.
See all obesity clinical trials recruiting in Tucson — not just this study.
Browse Obesity Trials in Tucson →